SPONSOR
Case Comprehensive Cancer Center
Total Trials
12
Recruiting
12
Phases
Phase 1, Phase 3, Phase 2
Conditions studied: Human Papilloma Virus Related CarcinomaTonsillar Squamous Cell CarcinomaRelapsed SarcomasCancerEpithelial Ovarian CancerCyst of PancreasPancreatectomyPancreas NeoplasmBrain MetastasesBreast Cancer
Case Comprehensive Cancer Center is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Human Papilloma Virus Related Carcinoma, Tonsillar Squamous Cell Carcinoma, Relapsed Sarcomas, Cancer.
The trial portfolio spans Phase 1, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Case Comprehensive Cancer Center
How many clinical trials has Case Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Case Comprehensive Cancer Center, of which 12 are actively recruiting participants. These trials cover conditions including Human Papilloma Virus Related Carcinoma, Tonsillar Squamous Cell Carcinoma, Relapsed Sarcomas. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Case Comprehensive Cancer Center research focus on?
Case Comprehensive Cancer Center clinical trials span Human Papilloma Virus Related Carcinoma, Tonsillar Squamous Cell Carcinoma, Relapsed Sarcomas, Cancer, Epithelial Ovarian Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Case Comprehensive Cancer Center clinical trial?
To participate in a Case Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Case Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Case Comprehensive Cancer Center
NCT07060261
Recruiting
Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma
Human Papilloma Virus Related Carcinoma
NCT05210374 Phase 1
Recruiting
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Relapsed Sarcomas
NCT07541365
Recruiting
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
Cancer
NCT06386887
Recruiting
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
Epithelial Ovarian Cancer
NCT05720338 Phase 3
Recruiting
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Cyst of Pancreas
NCT07248228 Phase 2
Recruiting
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Brain Metastases
NCT06129747 Phase 2
Recruiting
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Breast Cancer
NCT05610852
Recruiting
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Prostate Adenocarcinoma
NCT07117032 Phase 1
Recruiting
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
Pancreatic Cancer
NCT07129226
Recruiting
Musculoskeletal Cancers Remote Monitoring and Care
Osteosarcoma
NCT05469269
Recruiting
Cleveland African American Prostate Cancer Project
Prostate Cancer
NCT06627270 Phase 2
Recruiting
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Oral Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology